PSMA-based therapeutics for prostate cancer-Reference-Cited by-同舟云学术

PSMA-based therapeutics for prostate cancer

Published:2024-07-02 Issue:10 Volume:25 Page:1405-1419
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Stamatakos Panagiotis Velissarios¹,Fragkoulis Charalampos¹,Leventi Aggeliki¹,Gklinos Konstantinos¹,Kontolatis Nikolaos¹,Papatsoris Athanasios²^ORCID,Dellis Athanasios³

Affiliation:

1. Department of Urology, General Hospital of Athens “G. Gennimatas”, Athens, Greece

2. 2nd Department of Urology, School of Medicine, National and Kapodistrian University of Athens, Hospital of Athens “Sismanoglio”, Athens, Greece

3. 1st Department of Urology, School of Medicine, National and Kapodistrian University of Athens, Hospital of Athens “Aretaieion”, Athens, Greece

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2024.2385726

Reference124 articles.

1. Prostate-specific Membrane Antigen Biology in Lethal Prostate Cancer and its Therapeutic Implications

2. 177Lu-PSMA therapy in metastatic prostate cancer: An updated review of prognostic and predictive biomarkers

3. A systematic review on the current status of PSMA-targeted imaging and radioligand therapy

4. The Epidemiology of Prostate Cancer

5. Current status of PSMA-targeted imaging and therapy

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate Cancer: Emerging Modifiable Risk Factors and Therapeutic Strategies in the Management of Advanced Cancer;Life;2024-08-30